It’s Still All About Relationships: Why Sponsors, CROs, Patients, and Study Sites Are Key to Improving Performance

By Jeff Zucker, M.S., Senior Vice President, Clinical Operations and Trial Optimization,

Throughout the clinical trial industry, stakeholders are embracing the value of patient centricity in the execution of drug development research and in understanding real-world marketability. Recognizing the role of sites and investigators in supporting patient-focused studies, Jeff Zucker identifies six areas in which CROs might nurture site relations.

Read More